Quantcast

Latest Renal cell carcinoma Stories

2014-10-22 08:26:51

PHILADELPHIA, Pennsylvania, October 22, 2014 /PRNewswire/ -- In collaboration with West Cancer Center at University of Tennessee, the comprehensive Center of Excellence

2014-10-16 12:28:14

Launch of Novel Immune Checkpoint Inhibitors Will Fuel Market Growth and Will Dramatically Enhance RCC Treatment Algorithm, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-10-09 23:10:29

VHL Alliance fundraiser dinner with New York Times bestselling author, Tom Rath, honors NCI and NIH reasearher, W.

2014-09-27 08:21:23

- Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement(1) EAST HANOVER,

2014-09-24 04:21:41

WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.

2014-09-01 23:00:51

MarketOptimizer.org adds “EpiCast Report Renal Cell Carcinoma - Epidemiology Forecast to 2023” to its store.

2014-07-16 04:21:39

TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome

2014-07-07 08:22:14

-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.